Pradit Panjavenin

  • Citations Per Year
Learn More
BACKGROUND LDL and hs-CRP are risk factors for vascular events and can be modified by Statin. OBJECTIVE To evaluate the baseline hs-CRP of a certain Thai population who would need Atorvastatin, to evaluate the dose response of Atorvastatin toward LDL and hs-CRP level, and to evaluate the efficacy and safety of different types of Atorvastatin. MATERIAL(More)
  • 1